Eli Lilly (LLY.N) CEO: We need to know the number of patients receiving obesity drugs under the US Medicare drug plan, as well as the number of out-of-pocket patients outside the US, in order to forecast sales for 2026.
2026-01-14
Eli Lilly (LLY.N) CEO: We need to know the number of patients receiving obesity drugs under the US Medicare drug plan, as well as the number of out-of-pocket patients outside the US, in order to forecast sales for 2026.